UPXI Stock Overview A brand owner, engages in the development, manufacturing, and distribution of consumer products in pet, surgery, recovery, skin, beauty, health, and wellness markets. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Upexi Historical stock prices Current Share Price US$3.46 52 Week High US$33.00 52 Week Low US$2.17 Beta 0.13 1 Month Change -21.72% 3 Month Change -15.82% 1 Year Change -86.27% 3 Year Change -95.90% 5 Year Change n/a Change since IPO -96.91%
Recent News & Updates
Upexi Receives Notice from the Nasdaq Stock Market Nov 22
Upexi, Inc. announced delayed 10-Q filing Nov 15 Upexi, Inc. to Report Fiscal Year 2024 Results on Nov 01, 2024
Nasdaq Grants Additional 180 Days to Upexi to Regain Compliance with Minimum Bid Price Requirement Oct 03 Upexi, Inc. announced delayed annual 10-K filing Oct 01
Insufficient new directors Aug 15 See more updates
Upexi Receives Notice from the Nasdaq Stock Market Nov 22
Upexi, Inc. announced delayed 10-Q filing Nov 15 Upexi, Inc. to Report Fiscal Year 2024 Results on Nov 01, 2024
Nasdaq Grants Additional 180 Days to Upexi to Regain Compliance with Minimum Bid Price Requirement Oct 03 Upexi, Inc. announced delayed annual 10-K filing Oct 01
Insufficient new directors Aug 15 David Romano, Nick Romano and Eric Limont acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million. Aug 07
E-Core Holdings, LLC acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million. Aug 06
Upexi Provides Update on Filing Form 10Q for March 31, 2024 Jun 22
Upexi, Inc. to Report Q3, 2024 Results on Jun 24, 2024 Jun 21 MFA Holdings Corp., 1000915944 Ontario Inc and Nutraproducts LLC acquired VitaMedica Corporation from Upexi, Inc. (NasdaqCM:UPXI) for $6 million. Jun 18
Upexi, Inc. announced delayed 10-Q filing May 17
Upexi, Inc., Annual General Meeting, Jun 10, 2024 May 03
New major risk - Market cap size Apr 18 Upexi Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Under Nasdaq Listing Rule 5550(a)(2) Apr 03
Consensus revenue estimates fall by 17% Feb 22
Consensus revenue estimates fall by 17% Feb 21
This Analyst Just Downgraded Their Upexi, Inc. (NASDAQ:UPXI) EPS Forecasts Feb 17
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Feb 15
Insufficient new directors Feb 14
Upexi, Inc. Revises Preliminary and Unaudited Financial Guidance for the First Quarter Ended September 30, 2023 Nov 16 Upexi, Inc. announced delayed 10-Q filing
Upexi, Inc. Pet Care Brand, Luckytail, Announces Expansion of Product Line to Include All-Natural Dog Supplements Sep 15
Amplifyir Inc. acquired 100% stake in Interactive Offers LLC from Upexi, Inc. (NasdaqCM:UPXI) for $1.25 million. Sep 08
Upexi, Inc. (NASDAQ:UPXI) Doing What It Can To Lift Shares Jun 11
Upexi, Inc., Annual General Meeting, Jun 26, 2023 May 19
Third quarter 2023 earnings released: US$0.11 loss per share (vs US$0.003 loss in 3Q 2022) May 17
Investor sentiment deteriorates as stock falls 16% May 15
Upexi, Inc. announced delayed 10-Q filing Feb 16
Second quarter 2023 earnings released: EPS: US$0.17 (vs US$0.004 in 2Q 2022) Feb 16
CEO, President & Chairman of the Board recently bought US$73k worth of stock Dec 07
First quarter 2023 earnings released: US$0.15 loss per share (vs US$0.033 profit in 1Q 2022) Nov 17
High number of new and inexperienced directors Nov 16
Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of E-Core, Inc. Nov 03 Bloomios, Inc. (OTCPK:BLMS) acquired Infusionz, LLC from Upexi, Inc. (NasdaqCM:UPXI) for $23.5 million.
Upexi, Inc. Files Patent for its Single Click-to-optin Technology Oct 12
Upexi, Inc. Provides Revenue Guidance for the Fiscal Year 2023 Sep 30
Full year 2022 earnings released: US$0.13 loss per share (vs US$0.25 profit in FY 2021) Sep 29
Upexi, Inc. Appoints Anthony Bazan as Chief Operating Officer Sep 01
Investor sentiment deteriorated over the past week Aug 29
Grove, Inc. (NasdaqCM:GRVI) signed a non-binding LOI to acquire E-Core, Inc. Aug 03
Investor sentiment improved over the past week Aug 01
Grove CEO provides company update on sales and beyond Jul 13
Investor sentiment improved over the past week Jul 08
Grove, Inc.(NasdaqCM:GRVI) dropped from Russell Microcap Value Index Jun 26
Investor sentiment deteriorated over the past week Jun 09
Investor sentiment improved over the past week May 23
Grove, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022 May 18
Third quarter 2022 earnings released: US$0.003 loss per share (vs US$0.071 profit in 3Q 2021) May 16
High number of new and inexperienced directors Apr 27
Grove, Inc. (NasdaqCM:GRVI) acquired Cygnet Online LLC. Apr 21
Grove, Inc., Annual General Meeting, May 24, 2022 Apr 13
Investor sentiment improved over the past week Apr 04
Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint Feb 15
High number of new and inexperienced directors Dec 06
First quarter 2022 earnings released: EPS US$0.033 (vs US$0.078 loss in 1Q 2021) Nov 18
Investor sentiment improved over the past week Oct 14
Why Grove's (NASDAQ:GRVI) Earnings Are Weaker Than They Seem Oct 05
Full year 2021 earnings released: EPS US$0.25 (vs US$0.53 loss in FY 2020) Sep 30
Grove, Inc. (NasdaqCM:GRVI) signed a letter of intent to acquire Interactive Offers LLC. Aug 20
Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of VitaMedica Corporation. Aug 07
Grove: An Underrated CBD Player Jul 31
Grove, Inc. (NasdaqCM:GRVI) entered into a non binding letter of intent to acquire VitaMedica Corporation. Jul 01
Grove, Inc. has completed an IPO in the amount of $11 million. Jun 25 Shareholder Returns UPXI US Personal Products US Market 7D -5.4% 3.1% 3.2% 1Y -86.3% -20.3% 24.2%
See full shareholder returns
Return vs Market: UPXI underperformed the US Market which returned 24.2% over the past year.
Price Volatility Is UPXI's price volatile compared to industry and market? UPXI volatility UPXI Average Weekly Movement 53.7% Personal Products Industry Average Movement 8.4% Market Average Movement 6.5% 10% most volatile stocks in US Market 18.9% 10% least volatile stocks in US Market 3.2%
Stable Share Price: UPXI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: UPXI's weekly volatility has increased from 30% to 54% over the past year.
About the Company Upexi, Inc., a brand owner, engages in the development, manufacturing, and distribution of consumer products in pet, surgery, recovery, skin, beauty, health, and wellness markets. It sells its products through direct-to-consumer network, wholesale partnerships, and major third-party platform. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022.
Show more Upexi, Inc. Fundamentals Summary How do Upexi's earnings and revenue compare to its market cap? UPXI fundamental statistics Market cap US$3.60m Earnings (TTM ) -US$24.99m Revenue (TTM ) US$22.08m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) UPXI income statement (TTM ) Revenue US$22.08m Cost of Revenue US$11.76m Gross Profit US$10.33m Other Expenses US$35.32m Earnings -US$24.99m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -24.01 Gross Margin 46.76% Net Profit Margin -113.18% Debt/Equity Ratio 160.1%
How did UPXI perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/20 13:42 End of Day Share Price 2025/01/17 00:00 Earnings 2024/09/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Upexi, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Aaron Grey Alliance Global Partners Ishan Majumdar Baptista Research Benjamin Piggott D. Boral Capital LLC.
Show 0 more analysts 
